Using an App to Improve Hepatitis C Care
This study is testing a patient-centered electronic app designed to help people with Hepatitis C (HCV) understand their condition better. The app will use your lab results to show you how your liver is doing and provide personalized information about your HCV disease. Researchers want to see if using this app helps more people with HCV get linked to care, start treatment, and achieve a cure. You may be able to join if you are an adult (18-100 years old) who has tested positive for HCV at Johns Hopkins Hospital Emergency Department and do not have HCV RNA information. The study aims to enroll 308 participants, but its current status is unclear.
- Study design
- This is a randomized controlled clinical trial involving an estimated 308 participants. It will compare the impact of the educational app on HCV patients.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed to measure linkage to care rates for 28 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Yu-Hsiang Hsieh, PhD · PRINCIPAL_INVESTIGATOR · Johns Hopkins University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Linkage to care rate (days)28 months
Linkage to care rate is defined as the time (days) between patient enrollment and the patient's first HCV-related clinic visit.